Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.

Mannelli P, Wu LT, Peindl KS, Swartz MS, Woody GE.

Drug Alcohol Depend. 2014 May 1;138:83-8. doi: 10.1016/j.drugalcdep.2014.02.002. Epub 2014 Feb 15.

PMID:
24602363
[PubMed - in process]
2.

Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study.

Wu LT, Brady KT, Mannelli P, Killeen TK; NIDA AAPI Workgroup.

J Psychiatr Res. 2014 Mar;50:26-35. doi: 10.1016/j.jpsychires.2013.11.010. Epub 2013 Dec 1.

PMID:
24342767
[PubMed - in process]
3.

Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.

Wu LT, Blazer DG, Gersing KR, Burchett B, Swartz MS, Mannelli P; NIDA AAPI Workgroup.

J Psychiatr Res. 2013 Dec;47(12):1940-8. doi: 10.1016/j.jpsychires.2013.08.022. Epub 2013 Sep 9.

PMID:
24060266
[PubMed - indexed for MEDLINE]
4.

The burden of caring: drug users & their families.

Mannelli P.

Indian J Med Res. 2013 Apr;137(4):636-8. No abstract available.

PMID:
23703330
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Smoking and opioid detoxification: behavioral changes and response to treatment.

Mannelli P, Wu LT, Peindl KS, Gorelick DA.

Nicotine Tob Res. 2013 Oct;15(10):1705-13. doi: 10.1093/ntr/ntt046. Epub 2013 Apr 9.

PMID:
23572466
[PubMed - indexed for MEDLINE]
6.

Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults.

Wu LT, Swartz MS, Pan JJ, Burchett B, Mannelli P, Yang C, Blazer DG.

Gen Hosp Psychiatry. 2013 Jan-Feb;35(1):74-82. doi: 10.1016/j.genhosppsych.2012.06.014. Epub 2012 Jul 21.

PMID:
22819723
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Alcohol and drug use disorders among adults in emergency department settings in the United States.

Wu LT, Swartz MS, Wu Z, Mannelli P, Yang C, Blazer DG.

Ann Emerg Med. 2012 Aug;60(2):172-80.e5. doi: 10.1016/j.annemergmed.2012.02.003. Epub 2012 Mar 15.

PMID:
22424657
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Lee TH, Szabo ST, Fowler JC, Mannelli P, Mangum OB, Beyer WF, Patkar A, Wetsel WC.

Drug Alcohol Depend. 2012 Jul 1;124(1-2):11-8. doi: 10.1016/j.drugalcdep.2012.01.021. Epub 2012 Feb 21. Review.

PMID:
22356892
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.

Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. Review.

PMID:
22280332
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.

Mannelli P, Peindl K, Wu LT, Patkar AA, Gorelick DA.

Am J Drug Alcohol Abuse. 2012 May;38(3):200-5. doi: 10.3109/00952990.2011.644003. Epub 2012 Jan 10.

PMID:
22233189
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

An integrated alcohol abuse and medical treatment model for patients with hepatitis C.

Proeschold-Bell RJ, Patkar AA, Naggie S, Coward L, Mannelli P, Yao J, Bixby P, Muir AJ.

Dig Dis Sci. 2012 Apr;57(4):1083-91. doi: 10.1007/s10620-011-1976-4. Epub 2011 Dec 2.

PMID:
22134784
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo.

Mannelli P.

Evid Based Ment Health. 2011 Nov;14(4):106. doi: 10.1136/ebmh.2011.100153. No abstract available.

PMID:
22009238
[PubMed]
13.

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Mannelli P, Peindl KS, Wu LT.

Subst Abuse Rehabil. 2011 Jun;2011(2):113-123.

PMID:
21731898
[PubMed]
Free PMC Article
14.
15.

Problem drinking and low-dose naltrexone-assisted opioid detoxification.

Mannelli P, Peindl K, Patkar AA, Wu LT, Tharwani HM, Gorelick DA.

J Stud Alcohol Drugs. 2011 May;72(3):507-13.

PMID:
21513688
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.

Mannelli P, Peindl K, Patkar AA, Wu LT, Pae CU, Gorelick DA.

J Clin Psychopharmacol. 2010 Aug;30(4):476-8. doi: 10.1097/JCP.0b013e3181e5c168. No abstract available.

PMID:
20631574
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Opioid use affects antioxidant activity and purine metabolism: preliminary results.

Mannelli P, Patkar A, Rozen S, Matson W, Krishnan R, Kaddurah-Daouk R.

Hum Psychopharmacol. 2009 Dec;24(8):666-75. doi: 10.1002/hup.1068.

PMID:
19760630
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study.

Patkar AA, Rozen S, Mannelli P, Matson W, Pae CU, Krishnan KR, Kaddurah-Daouk R.

Psychopharmacology (Berl). 2009 Oct;206(3):479-89. doi: 10.1007/s00213-009-1625-1. Epub 2009 Aug 1.

PMID:
19649617
[PubMed - indexed for MEDLINE]
20.

Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.

Pae CU, Marks DM, Masand PS, Peindl K, Hooper-Wood C, Han C, Mannelli P, Ciccone P, Patkar AA.

Clin Neuropharmacol. 2009 Mar-Apr;32(2):85-8. doi: 10.1097/WNF.0b013e31817e559b.

PMID:
19512961
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk